| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.33 | 1e-09 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-07 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-07 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.26 | 5e-06 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.18 | 6e-06 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.25 | 9e-06 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-05 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-05 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-05 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0002 |